What Is Merck & Company, Inc. (MRK) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Merck & Company, Inc.'s intrinsic value is estimated at $66.98. Trading at its current price of $124.03, the valuation engine raises significant caution: 12 of 13 models flag downside risk, projecting an average implied return of -46.0%. The most optimistic model, RCMH-DCF, places fair value at $136.57 (+10.1%), while Dynamic NAV — the most conservative — estimates $10.72 (-91.4%). This +101.5% gap reflects genuine analytical uncertainty about Merck & Company, Inc.'s intrinsic worth. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.
What Do the Models Say About MRK?
13 of 13 models are currently active for MRK. Of these, 1 model suggests upside while 12 models suggest overvaluation. The Bayesian DCF estimates MRK's intrinsic value at $92.70, implying -25.3% downside from the current price. See which stocks rank higher →
How Does MRK Rank in Pharmaceutical Preparations?
Among 440 Pharmaceutical Preparations stocks, MRK ranks #11 by Quality of Company score. CirclFi's QOC score of 9.6/10 evaluates 32 fundamental signals. A score of 9.6 places MRK in the top tier.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Merck & Company, Inc.'s positioning within the Pharmaceutical Preparations segment means that R&D productivity ratio plays an outsized role in fundamental analysis. The sector's unique characteristics — including regulatory pathway clarity — shape both the opportunity set and risk profile.
Is MRK a Value Trap?
The Value Trap algorithm is not active for MRK. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Merck & Company, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Merck & Company, Inc. scores 9.6 out of 10 on our 32-signal quality assessment, a elite rating that ranks among the highest-quality businesses in our coverage universe. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +101.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every MRK valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across MRK's 13 active models, average confidence is 51%. Moderate confidence indicates reasonable fit.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad